Search - tctmd.com

Displaying 61 - 80 of 85

Sort: Relevancy | Date

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Presentation TCT 2017

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Presenter: Eberhard Grube, James B. Hermiller Jr., Megan Coylewright

November 01, 2017

Presentation TCT 2017

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #3 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Case Study #2 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Presenter: Lee N. Benson, Megan Coylewright, Guillaume Turc

November 01, 2017

Presentation TCT 2017

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Case Study #1 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

Presenter: Lee N. Benson, Megan Coylewright

November 01, 2017

Presentation TCT 2017

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

The PFO Clinic: Neurologists and Cardiologists as a Team

Presenter: Lee N. Benson, Megan Coylewright, Lars Sondergaard

November 01, 2017

Presentation LAA 2017

LAA Closure: Shared Decision Making Criteria and Documentation

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Presenter: Megan Coylewright

July 21, 2017

Presentation TVT 2016

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

Presenter: Megan Coylewright, MD

June 16, 2016

Presentation TVT 2014

Transcatheter Mitral Valve-in-Ring

Presenter: Megan Coylewright

June 05, 2014

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

Advertisement

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Shared Decision-making is an Essential Component of the Modern-era Heart Team: Rationale and Integration with TAVR Clinical Practice

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Case Study #3 Introduction: To Close or Not to Close?

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Case Study #2 Introduction: To Close or Not to Close?

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? No!

Debate: Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? Yes!

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Case Study #1 Introduction: To Close or Not to Close?

Shared Decision-making for PFO Closure: How to Make the FDA Requirements Work

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

The PFO Clinic: Neurologists and Cardiologists as a Team

LAA Closure: Shared Decision Making Criteria and Documentation

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

TVT 1071: Reduction of Left Ventricular Outflow Gradient in the Context of Septal Hypertrophy With Transcatheter Mitral Valve Repair

Transcatheter Mitral Valve-in-Ring

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content